Concerta is the most widely recognized and frequently prescribed extended-release formulation of methylphenidate in 2026, used daily by millions of children, adolescents and adults diagnosed with attention deficit hyperactivity disorder (ADHD) and, in some markets, narcolepsy. The distinctive OROS (osmotic-controlled release oral delivery system) technology inside each tablet releases methylphenidate in two phases: an immediate […]